Top compounds associated with response to IFNA4


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CTRPv2 pan-cancer AAC -0.023 0.5
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.023 0.5
mRNA apicidin CTRPv2 pan-cancer AAC 0.022 0.5
mRNA Bax channel blocker CTRPv2 pan-cancer AAC -0.027 0.5
mRNA JQ-1 GDSC1000 pan-cancer AAC -0.024 0.5
mRNA THZ-2-102-1 GDSC1000 pan-cancer AAC 0.022 0.5
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA paclitaxel CTRPv2 pan-cancer AAC 0.023 0.5
mRNA VAF-347 CTRPv2 pan-cancer AAC -0.033 0.5
mRNA Nilotinib CTRPv2 pan-cancer AAC 0.026 0.5
Download CSV